课题基金 / 基金详情

Role of the Amyloid Precursor Protein in the cellular phosphoinositide metabolism through its interaction with the PIKfyve complex

Role of the Amyloid Precursor Protein in the cellular phosphoinositide metabolism through its interaction with the PIKfyve complex
淀粉样前体蛋白通过与 PIKfyve 复合物相互作用在细胞磷酸肌醇代谢中的作用
批准号:
BB/K014862/1
负责人:
Zita Balklava
金额:
$46.97万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
While the role of the Amyloid Precursor Protein APP in Alzheimer's disease is well established, its normal role in organisms is ill defined. As most proteins that fulfill complex functions do so in concert with other proteins that they physically bind (so-called interaction partners), knowing binding partners can give valuable insights into protein function. We have established a large number of binding partners of APP, among them a protein complex consisting of the subunits PIKfyve, Vac14 and Fig4. These three proteins are well known to regulate the levels of an important signalling lipid, phosphatidylinositol-3,5-bisphosphate (PI3,5P2). Interestingly, loss of Vac14 or Fig4 lead to profound neurodegeneration in mice as well as humans. The fact that both APP and the PIKfyve complex are implicated in neurodegeneration and the fact that they bind each other is novel and surprising. This suggests that both participate in the same cellular process. We suggest that APP is a regulator of PI3,5P2 via its binding of the PIKfyve complex. We now need to test whether this hypothesis is correct. We will test this idea using the genetic model organism C. elegans. In this simple organism there are genes that are highly similar to human APP, PIKfyve, Vac14 and Fig4. The powerful advantage of using C. elegans is the availability of numerous mutants. We have obtained mutants in which APP, PIKfyve and Vac14 are defective. We will characterise the consequences of these defects in animals in terms of appearance of the animals, their behavior and the integrity of their neuronal system. In the next step, through crossing the APP mutants with PIKfyve or Vac14 animals we can combine the mutations in one animal. This then allows to compare the consequences of the double mutants with the single mutants and allows to deduce whether genes act in concert to fulfill a biological function (termed a genetic interaction). We predict that the double mutants will have a strongly enhanced phenotype compared to the single mutants. This type of phenotypic enhancement is only observed when several genes are functionally connected. This type of approach provides invaluable information that cannot be obtained by any other approach. We will also analyse the levels of the signalling lipid PI3,5P2 that appears to be of key importance for the integrity of the central nervous system. Correlating the levels of this with the characteristics of the animals (appearance, behavior etc.) will allow us to understand what role APP and the PIKfyve complex play in its regulation. Our work suggests that the transmembrane receptor (APP) is able to module the production of PI3,5P2 by a direct interaction with the PIKfyve complex. Loss of function of the PIKfyve complex is known to lead to neurodegeneration in mammals. Our work for the very first time links APP with PI3,5P2 regulation and thus may provide an entirely novel and unexpected mechanism how loss or aberrant processing of APP can instigate neurodegeneration.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1042/bsr20160040
发表时间: 2016
期刊: Bioscience reports
影响因子: 4
作者: [Guscott B, Balklava Z, Safrany ST, Wassmer T]
通讯作者: Wassmer T
DOI: 10.1007/s00018-015-1993-0
发表时间: 2016-01
期刊: Cellular and molecular life sciences : CMLS
影响因子: --
作者: [Currinn H, Guscott B, Balklava Z, Rothnie A, Wassmer T]
通讯作者: Wassmer T
国内基金
海外基金
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
  • 批准号:
    22077118
  • 项目类别:
    面上项目
  • 资助金额:
    63.0万元
  • 批准年份:
    2020
  • 负责人:
    高楠
  • 依托单位:
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
  • 批准号:
    81870666
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    王海燕
  • 依托单位:
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
  • 批准号:
    81601123
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    17.0万元
  • 批准年份:
    2016
  • 负责人:
    都瑾
  • 依托单位:
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
  • 批准号:
    30971012
  • 项目类别:
    面上项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2009
  • 负责人:
    刘瑞田
  • 依托单位: